Literature DB >> 33881806

Improving medicine concordance in a patient with Parkinson's and dementia: a case study.

Claire Soper1.   

Abstract

Parkinson's is a progressive neurological condition characterised by a range of debilitating motor and non-motor symptoms and often leading to the development of Parkinson's dementia. People with Parkinson's need to take antiparkinsonian medicines at frequent and regular intervals to control their symptoms. However, concordance with medicines is often suboptimal, with some people taking excessive doses to alleviate their symptoms or forgetting to take their medicines. For people with Parkinson's living at home, monitoring and support from a community Parkinson's nurse specialist (CPNS), in coordination with local services, can assist them in managing their medicines and enable them to remain safely in their own home. This article discusses the case of one patient and the interventions provided to her over a six-month period by the CPNS, alongside the community multidisciplinary team, to improve her medicine concordance and ensure her safety.
© 2021 RCN Publishing Company Ltd. All rights reserved. Not to be copied, transmitted or recorded in any way, in whole or part, without prior permission of the publishers.

Entities:  

Keywords:  Parkinson’s; clinical; concordance; dementia; falls; medicines; medicines management; nervous system diseases; neurology; older people; patient safety; patients; professional

Mesh:

Substances:

Year:  2021        PMID: 33881806     DOI: 10.7748/nop.2021.e1301

Source DB:  PubMed          Journal:  Nurs Older People        ISSN: 1472-0795


  1 in total

1.  SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration.

Authors:  Alessio Ardizzone; Valentina Bova; Giovanna Casili; Alessia Filippone; Michela Campolo; Marika Lanza; Emanuela Esposito; Irene Paterniti
Journal:  J Neuroinflammation       Date:  2022-05-07       Impact factor: 9.587

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.